Figure 2. Influence of the genotype at rs10490924 (A69S) in age-related maculopathy susceptibility 2 on the time course of the logMAR best-corrected visual acuity (BCVA) value was evaluated in all typical neovascular age-related macular degeneration (tAMD) patients treated by photodynamic therapy (PDT). All values are presented as means±standard error of the mean (SEM). The TT genotype shows a significant worsening of their mean BCVA at 12 months (** p<0.01).